We make them accessible.
It’s also the science.
MAY 14, 2019 | IBD News Today Two Israeli pharmaceutical companies are collaborating with a medical cannabis company to develop what’s being touted as the first
03 May 2019 | Bio Spectrum Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd.,
Panaxia and Rafa sign a collaboration agreement with PlantEXT to research and manufacture the first medical cannabis suppositories intended for patients suffering from inflammatory bowel disease (“IBD”, Crohn’s and colitis)
May 01, 2019 | Bio Space Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical
Apr 22, 2019 | Forbes Earlier this year, Israel-based pharmaceutical cannabis company Panaxia Pharmaceutical Industries appointed Nobel Prize winner in chemistry, Prof. Aaron Ciechanover (72) as a senior member on its advisory
March 26, 2019 | Market Screener Panaxia Israel Pharmaceutical Industries, which manufactures medical cannabis treatments, announced today Jonathan Kolber’s appointment as Chairman of the merged company –
Breaking News for cancer patients treated with medical cannabis: Breakthrough in Panaxia clinical research to deliver medical cannabis through metered-dose inhaler
Mar. 4, 2019 | Business Insider Panaxia in collaboration with the Israeli Pharmaceutical company “Rafa”, has begun a clinical research of medical cannabis concentrates for